Instead, it may indicate changes in gut microbiota or the intestinal ecosystem
supports insulin sensitivity Nervous System: Protects against neurodegeneration and cognitive decline Skin: Improves autoimmune conditions and accelerates wound healing Future Applications of GLP-1 Medications As clinical trials continue, GLP-1 receptor agonists may soon be approved for: Neurodegenerative diseases: Alzheimers, Parkinsons, MS Autoimmune conditions: Psoriasis, RA, Lupus Cardiometabolic syndromes: NAFLD, PCOS, atherosclerosis Pulmonary conditions: Chronic bronchitis, COPD, even long-COVID inflammation Final Thoughts GLP-1 medications are no longer just diabetes or weight loss drugs
The Precision Peptide Genetic Test maps variants in GLP1R, GIPR, FTO, and MC4R, which influence inflammatory and metabolic responses to tirzepatide
Support Groups Support groups, whether professionally or peer led, are helpful resources when you feel as though you need that extra level of understanding